MedPath
NMPA Approval

Vortioxetine Hydrobromide Tablets

国药准字H20233417

April 4, 2023

Drug Information

氢溴酸伏硫西汀片

片剂

10mg(以C₁₈H₂₂N₂S计)

化学药品

April 4, 2023

Company Information

Applicant Company

石家庄经济技术开发区塔西大街6号

Manufacturing Company

石家庄经济技术开发区塔西大街6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氢溴酸伏硫西汀片 - NMPA 批准文号 | MedPath